Abstract
Checkpoint-1 kinase plays an important role in the G2M cell cycle control, therefore its inhibition by small molecules is of great therapeutic interest in oncology. In this paper, we have reported the virtual screening of an in-house library of 2499 pyranopyrazole derivatives against the ATP-binding site of Chk1 kinase using Glide 5.0 program, which resulted in six hits. All these ligands were docked into the site forming most crucial interactions with Cys87, Glu91 and Leu15 residues. From the observed results these ligands are suggested to be potent inhibitors of Chk1 kinase with sufficient scope for further elaboration.
Keywords: Chk-1, Docking, Drug Design, Oncology, Pyranopyrazoles, Glide
Letters in Drug Design & Discovery
Title: Computer-Aided Drug Design of Pyranopyrazoles and Related Compounds for Checkpoint Kinase-1
Volume: 6 Issue: 8
Author(s): Rahul Ramtekkar, Kandhasamy Kumarvel, Gnanasambandam Vasuki, K. Sekar and R. Krishna
Affiliation:
Keywords: Chk-1, Docking, Drug Design, Oncology, Pyranopyrazoles, Glide
Abstract: Checkpoint-1 kinase plays an important role in the G2M cell cycle control, therefore its inhibition by small molecules is of great therapeutic interest in oncology. In this paper, we have reported the virtual screening of an in-house library of 2499 pyranopyrazole derivatives against the ATP-binding site of Chk1 kinase using Glide 5.0 program, which resulted in six hits. All these ligands were docked into the site forming most crucial interactions with Cys87, Glu91 and Leu15 residues. From the observed results these ligands are suggested to be potent inhibitors of Chk1 kinase with sufficient scope for further elaboration.
Export Options
About this article
Cite this article as:
Ramtekkar Rahul, Kumarvel Kandhasamy, Vasuki Gnanasambandam, Sekar K. and Krishna R., Computer-Aided Drug Design of Pyranopyrazoles and Related Compounds for Checkpoint Kinase-1, Letters in Drug Design & Discovery 2009; 6 (8) . https://dx.doi.org/10.2174/157018009789353455
DOI https://dx.doi.org/10.2174/157018009789353455 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radiolabeled Nucleosides for Predicting and Monitoring the Cancer Therapeutic Efficacy of Chemodrugs
Current Medicinal Chemistry Molecular Testing and Personalized Treatment of Lung Cancer
Current Molecular Pharmacology Breast Cancer Chemoprevention: Current Perspectives
Current Enzyme Inhibition Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery The Impact of HAART on HPV-Related Cervical Disease
Current HIV Research Antioxidant Agents in Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics
Current Cancer Drug Targets New Developments in Systemic Therapy for Hepatocellular Carcinoma
Current Cancer Therapy Reviews Innovative Formulations for the Controlled and Site-specific Delivery of Antiinflammatory Drugs
Current Pharmaceutical Design Management of Ovarian Cancer In Younger Women
Reviews on Recent Clinical Trials γ δ T Cells and Dendritic Cells: Close Partners and Biological Adjuvants for New Therapies
Current Molecular Medicine Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Interaction of Mesalasine (5-ASA) with Translational Initiation Factors eIF4 Partially Explains 5-ASA Anti-Inflammatory and Anti-Neoplastic Activities
Medicinal Chemistry Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway
Current Cancer Drug Targets Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Current Pharmaceutical Design Management of Ovarian Cancer in Elderly
Reviews on Recent Clinical Trials Targeting of Cancer-Related Proteins with PNA Oligomers
Current Cancer Drug Targets Synthesis of Sulfur Containing Colchicine Derivatives and their Biological Evaluation as Cytotoxic Agents
Letters in Drug Design & Discovery Microscopies at the Nanoscale for Nano-Scale Drug Delivery Systems
Current Drug Targets